Physician

Vishwanath Hande, MD

According to 2025 Medicare claims, Vishwanath Hande, MD (NPI: 1528068004) practices internal medicine in the Burlington, NC market, with the plurality of this provider's patient population coming from Alamance, NC. This provider's primary affiliated billing organization is DUKE HEALTH INTEGRATED PRACTICE, INC. (NPI: 1205553369; TIN: 862109896) and primary practice location at 27215-8700. Hande is affiliated with the Duke Connected Care, LLC (ACO ID: A2419) and Triad HealthCare Network, LLC. (ACO ID: D0209), participating under both the MSSP and REACH models.

Hande's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 370 traditional Medicare patients, billed 6,118 HCPCS/CPT codes, and received $133,818 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 18,518 prescription claims across 960 beneficiaries totaling $1,440,803 in drug costs, led by Ozempic (Semaglutide). DME data shows 301 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $847,485 to $1,440,803. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $24,239 and ending at $22,325.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	453	6,427	$148,541
2016	396	5,776	$136,268
2017	385	6,442	$144,904
2018	445	7,130	$152,492
2019	458	6,801	$171,140
2020	450	6,713	$152,468
2021	419	6,594	$170,472
2022	392	6,491	$152,120
2023	380	6,005	$141,237
2024	370	6,118	$133,818

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	796	18,037	$847,485
2016	801	20,042	$900,941
2017	844	20,975	$938,608
2018	891	21,928	$1,076,264
2019	890	20,991	$1,159,318
2020	996	21,743	$1,325,699
2021	966	20,644	$1,426,364
2022	932	19,979	$1,499,588
2023	931	18,944	$1,596,639
2024	960	18,518	$1,440,803

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	139	435	$14,717
2016	127	564	$17,279
2017	72	487	$15,185
2018	153	504	$14,973
2019	145	566	$18,482
2020	162	663	$26,536
2021	177	541	$21,983
2022	120	463	$18,055
2023	119	322	$19,791
2024	86	301	$13,802

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	231	410	$73
80053	Blood test, comprehensive group of blood chemicals	234	440	$10
36415	Insertion of needle into vein for collection of blood sample	233	482	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	235	445	$8
81001	Manual urinalysis test with examination using microscope, automated	227	436	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	196	8,744	$259,139
Januvia	Sitagliptin Phosphate	110	6,611	$123,357
Eliquis	Apixaban	125	6,318	$121,230
Rybelsus	Semaglutide	78	2,850	$90,928
Trulicity	Dulaglutide	46	2,022	$69,002

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	13	$2,847
A7031	Face mask interface, replacement for full face mask, each	N	N/R	26	$2,275
A7030	Full face mask used with positive airway pressure device, each	N	13	32	$2,208
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	17	37	$1,321
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	17	$1,226

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Vishwanath Hande, MD?

Tedicare shows public-source Medicare data for Vishwanath Hande, MD (NPI 1528068004), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vishwanath Hande, MD have ACO affiliation data?

Vishwanath Hande, MD is shown with ACO affiliation data for Duke Connected Care, LLC (MSSP, ACO ID A2419) and Triad HealthCare Network, LLC. (REACH, ACO ID D0209).

What billing organization is linked to Vishwanath Hande, MD?

Vishwanath Hande, MD is linked to DUKE HEALTH INTEGRATED PRACTICE, INC. (billing NPI 1205553369) in the available physician profile data.

Does Vishwanath Hande, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.